Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Posts 7 Percent Q1 Revenue Growth

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer reported after the close of the market Thursday that its first-quarter revenues increased 7 percent, with a 4 percent benefit from acquisitions and a 1 percent contribution from acquisitions.

The Waltham, Mass.-based firm reported total revenues of $465.1 million for the three-month period ended April 4, compared to $435.2 million for the first quarter of 2009. Sales for its Human Health segment increased 6 percent to $188.6 million from $177.3 million, while sales for its Environmental Health segment increased 19 percent to $276.5 million from $257.9 million.

The firm surpassed analysts' consensus expectations for revenues of $446.8 million.

PerkinElmer posted a profit of $24.4 million, or $.21 per share, compared to $10.6 million, or $.09 per share, for the first quarter of 2009. Its adjusted EPS was $.31, beating analysts' consensus estimate of $.29.

The firm's R&D spending rose 3 percent to $27.1 million from $26.2 million, while its SG&A spending increased around 2 percent to $132.1 million from $129.1 million.

PerkinElmer finished the quarter with $181.7 million in cash and cash equivalents.

The firm expects its full-year 2010 GAAP EPS to be between $1.08 and $1.13, and non-GAAP EPS of between $1.43 and $1.48.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.